Jonathan M. Ahmann

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia”.

SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0168

N/A

0DataRank · unranked

61 citations

Anca Franzini, Anthony D. Pomicter, Brayden J. Halverson, Orlando Antelope, Clinton C. Mason +26 more

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism

Clinical and Translational Medicine(2022)10.1002/ctm2.1146

N/A

0DataRank · unranked

17 citations

Idaly M. Olivas, Alfonso E. Bencomo‐Alvarez, Andres J. Rubio, Christian Barreto‐Vargas, José López +25 more

A Bayesian framework to study tumor subclone–specific expression by combining bulk DNA and single-cell RNA sequencing data

Genome Research(2024)10.1101/gr.278234.123

N/A

0DataRank · unranked

4 citations

Xiaomeng Huang, Philip J. Moos, Jonathan M. Ahmann, Anthony D. Pomicter, Michael W. Deininger +5 more

Clonal dynamics of aggressive systemic mastocytosis on avapritinib therapy

Blood Cancer Journal(2024)10.1038/s41408-024-01157-w

N/A

0DataRank · unranked

0 citations

Anthony D. Pomicter, Jonathan M. Ahmann, Yi Qiao, Opal S. Chen, Tracy I. George +5 more